GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascentage Pharma Group International (HKSE:06855) » Definitions » Days Payable

Ascentage Pharma Group International (HKSE:06855) Days Payable : 885.05 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Ascentage Pharma Group International Days Payable?

Ascentage Pharma Group International's average Accounts Payable for the six months ended in Dec. 2023 was HK$65.7 Mil. Ascentage Pharma Group International's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$13.6 Mil. Hence, Ascentage Pharma Group International's Days Payable for the six months ended in Dec. 2023 was 885.05.

The historical rank and industry rank for Ascentage Pharma Group International's Days Payable or its related term are showing as below:

HKSE:06855' s Days Payable Range Over the Past 10 Years
Min: 218.75   Med: 1514.25   Max: 5126.12
Current: 867.29

During the past 8 years, Ascentage Pharma Group International's highest Days Payable was 5126.12. The lowest was 218.75. And the median was 1514.25.

HKSE:06855's Days Payable is ranked better than
83.08% of 721 companies
in the Biotechnology industry
Industry Median: 148.78 vs HKSE:06855: 867.29

Ascentage Pharma Group International's Days Payable declined from Dec. 2022 (997.35) to Dec. 2023 (885.05). It may suggest that Ascentage Pharma Group International accelerated paying its suppliers.


Ascentage Pharma Group International Days Payable Historical Data

The historical data trend for Ascentage Pharma Group International's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascentage Pharma Group International Days Payable Chart

Ascentage Pharma Group International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial 1,591.08 3,308.02 5,126.12 1,437.41 1,015.84

Ascentage Pharma Group International Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,208.14 2,903.63 997.35 730.23 885.05

Competitive Comparison of Ascentage Pharma Group International's Days Payable

For the Biotechnology subindustry, Ascentage Pharma Group International's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascentage Pharma Group International's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's Days Payable distribution charts can be found below:

* The bar in red indicates where Ascentage Pharma Group International's Days Payable falls into.



Ascentage Pharma Group International Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ascentage Pharma Group International's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (106.712 + 79.239) / 2 ) / 33.407*365
=92.9755 / 33.407*365
=1,015.84

Ascentage Pharma Group International's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (52.194 + 79.239) / 2 ) / 13.551*365 / 2
=65.7165 / 13.551*365 / 2
=885.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ascentage Pharma Group International Days Payable Related Terms

Thank you for viewing the detailed overview of Ascentage Pharma Group International's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascentage Pharma Group International (HKSE:06855) Business Description

Traded in Other Exchanges
Address
68 Xinqing Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215000
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company's geographical segments include the United States and Mainland China.
Executives
Ascentage Limited
Gao Sharon Xia
Guo Edward Ming
Healthquest Pharma Limited
Li Ju-yun
Wang Shaomeng
Yang Dajun
Zhai Yifan
South Dakota Trust Company Llc 2301 Trustee
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Tian Yuan 2201 Interest of corporation controlled by you
Zhao Li 2202 Interest of your spouse
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin You Xian He Huo 2201 Interest of corporation controlled by you
Xian Jin Zhi Zao Chan Ye Tou Zi You Xian Gong Si 2101 Beneficial owner
Guo Tou Chuang Xin Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you

Ascentage Pharma Group International (HKSE:06855) Headlines

No Headlines